Cargando…
Pharmacogenomics in the United States Community Pharmacy Setting: The Clopidogrel-CYP2C19 Example
Pharmacogenomics (PGx) is expanding across health-care practice settings, including the community pharmacy. In the United States, models of implementation of PGx in the community pharmacy have described independent services and those layered on to medication therapy management. The drug–gene pair of...
Autores principales: | Kisor, David F, Petry, Natasha J, Bright, David R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8140945/ https://www.ncbi.nlm.nih.gov/pubmed/34040417 http://dx.doi.org/10.2147/PGPM.S224894 |
Ejemplares similares
-
Pharmacogenomic Impact of CYP2C19 Variation on Clopidogrel Therapy in Precision Cardiovascular Medicine
por: Brown, Sherry-Ann, et al.
Publicado: (2018) -
Barriers, solutions, and effect of using pharmacogenomics data to support opioid prescribing
por: Bright, David, et al.
Publicado: (2020) -
Genetic Testing for CYP450 Polymorphisms to Predict Response to Clopidogrel: current evidence and test availability: Application: Pharmacogenomics
por: Ned, Renée M.
Publicado: (2010) -
Co-designing a community pharmacy pharmacogenomics testing service in the UK
por: Rendell, Tim, et al.
Publicado: (2022) -
Expanding Pharmacist and Student Pharmacist Access to Genetics/Genomics/Pharmacogenomics Competency Education
por: Kisor, David F, et al.
Publicado: (2019)